Influenza Diagnostics Industry Overview, Leading Players, Growth and Demand Forecast Report, 2028

Market Overview:
The global Influenza Diagnostics Market was valued at USD 0.86 billion in 2021 and is expected to reach USD 1.3 billion by the year 2028, at a CAGR of 7.4%.

Flu, prominently known as influenza, is a respiratory problem brought about by an infection. Coughing and sneezing usually carry the flu virus from one person to another. Likewise, one can get seasonal influenza by contacting a tainted surface with the seasonal infection on it, and then contacting the nose or eyes. Seasonal flu is when the flu is most prevalent at certain times of the year. In addition, millions of Americans contract the flu each flu season in the United States, which can begin as early as October and end as late as May. Muscle aches, fever, and other unpleasant symptoms are common flu symptoms, but most people recover within a week.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭:
https://introspectivemarketresearch.com/reports/influenza-diagnostics-market/

Market Dynamics:
Driver:
The need for precise influenza virus detection has grown in recent years as the number of influenza outbreaks has increased. Additionally, influenza diagnostic tests aid in confirming or excluding the presence of the virus in symptomatic individuals, which will propel the Influenza Diagnostic Market's expansion over the forecast period. Pregnant women, children, and the elderly were particularly susceptible to severe illness or death from influenza in 2019, according to a WHO report.

Opportunities:
Growing Need for Early Detection of the Influenza Virus
Market participants have a significant opportunity to develop diagnostics tests that are quick and accurate in order to meet the growing demand for early influenza virus detection and the rise in the number of cases. In addition, to lessen the financial burden imposed by the widespread influenza virus, governments worldwide are investing in the research and development of influenza diagnostic tests. Additionally, the Human Genome Project's technological advancements in genomics and proteomics have led to the creation of novel methods for diagnosing infections.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐩𝐚𝐠𝐞𝐬 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭:
https://introspectivemarketresearch.com/request/15919

Market Segmentation
Based on test type, the Influenza Diagnostic Market is segmented into traditional and molecular tests. The Rapid Influenza Detection Tests (RIDTs) a type of traditional test segment is forecasted to dominate the Influenza Diagnostic Market. The ability to detect influenza viruses within 15 minutes with low to moderate sensitivity and high specificity is the important factor driving the growth of this segment. Moreover, an analyzer reader device can be utilized to improve the sensitivity of RIDTs and standardize its results. Many RIDTs are the Clinical Laboratory Improvement Amendment (CLIA) waived, that's means they are very simple to perform and do not need scientifically qualified personnel. The RT-PCR test from the molecular test segment is expected to have the highest growth rate in the forecast period. RT-PCR test can detect current infection of influenza, enabling the healthcare provider to determine who is currently infected and who is not. Moreover, it is a highly sensitive test that can detect the presence of influenza virus in low concentration as well, therefore, stimulating the rapid development of the RT PCR test in the forecast period.
Traditional
• Rapid Influenza Detection Tests
• Viral Culture
• Immunoassay Kits
• Others
Molecular
• Rapid Molecular Assays
• Reverse Transcription-Polymerase Chain Reaction {Rt-Pcr}
• Nucleic Acid Amplification

Based on end-users, the diagnostic laboratories segment is expected to lead the Influenza Diagnostic Market throughout the forecast. The rising number of diagnostic laboratories and the increase in outsourcing of diagnostic testing services to large commercial diagnostic laboratories by hospitals is the vital factor promoting the development of this segment. Moreover, the well-deployed collection centers of large commercial diagnostic laboratories and the discounts offered by diagnostic laboratories on expensive tests are further propelling the expansion of this segment.
• Clinical Laboratories
• Hospitals
• Research & Academic Institutes
• Diagnostic Laboratories

Regional Analysis of Influenza Diagnostics Market:
The North American region is forecasted to have the highest share of the Influenza Diagnostic Market in the period of forecast. The presence of top leading companies involved in the manufacturing of Influenza Diagnostic products and the huge spending of governments on the development of novel fast diagnosing techniques to detect influenzas is the main factor supporting the expansion of the Influenza Diagnostic Market in this region. The high prevalence of seasonal flu and the rise in the adoption of technologically advanced diagnostic products is further boosting the growth of the Influenza Diagnostic Market in the forecast period.

The Europe region followed by North America is anticipated to have the second-highest share of the Influenza Diagnostic Market throughout the forecast. The presence of top research and academic institutes, and the increase in the research and development activities supported by governments funding are the vital factors fueling the Influenza Diagnostic Market growth in this region. Moreover, the rising incidences of bird flu, influenzas, and increasing demand for early detection of flu diseases are spurring the expansion of the Influenza Diagnostic Market in this region.

The Asia-Pacific region is expected to grow at the highest growth rate during the forecast period. A large number of an aging population and their high susceptibility to various diseases including influenza is the prominent factor driving the growth of the Influenza Diagnostic Market in this region. Moreover, the initiatives taken by governments in this region to enable faster diagnosis have facilitated easy access to over-the-counter tests that are user-friendly and assist in timely diagnosis. The wide use of rapid influenza diagnostics tests is propelling the development of the Influenza Diagnostic Market in this region.
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of SA)

𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:
https://introspectivemarketresearch.com/custom-research/15919

Players Covered in Influenza Diagnostics market are :
• Danaher Corporation (US)
• Siemens Healthineers (Germany)
• Thermo Fisher Scientific Inc. (US)
• F. Hoffmann-LA Roche AG (Switzerland)
• Abbott Laboratories Inc. (Us)
• Hologic Inc. (US)
• bioMérieux SA (France)
• Quidel Corporation (US)
• Becton
• Dickinson and Company (US)
• Meridian Bioscience (US)
• GenMark Diagnostics Inc. (US)
• Luminex Corporation (US)
• Tecan Trading AG (Switzerland)
• DiaSorin SA (Italy)
• altona Diagnostics GmbH (Germany)
• SEKISUI Diagnostics (US)
• SA Scientific Ltd. (US)
• Coris BioConcept SPRL (Belgium)
• ELITech Group (France)
• Mast Group Ltd. (UK)
• Genome Diagnostics Pvt. Ltd. (India)
• Germaine Laboratories Inc. (US)
• Response Biomedical Corp. (Canada)
• Tauns LaboratoriesInc. (Japan)
• 3B BlackBio Biotech India Ltd. (India) and Others major players.

Key Industry Developments in Influenza Diagnostics Market:
In March 2021, BD (Becton, Dickinson, and Company), a top global provider of influenza diagnostic products, declared that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a novel, rapid antigen test that can detect influenza A, influenza B and SARS-CoV-2 in a single test. The BD Veritor System developed for Rapid Detection of SARS-CoV-2 and Flu A+B assay requires only 15 minutes to run on the BD Veritor Plus System and differentiates between SARS-CoV-2, influenza A and influenza B, by giving conclusive positive or negative individual digital display readouts for all the three viruses.

In July 2021, DiaSorin SpA, a global diagnostic company, declared that it has completed the takeover of Luminex Corporation. Through the acquisition, DiaSorin will be able to access the multiplexing technology of Luminex and a portfolio that will consolidate the DiaSorin existing offering, while promoting the expansion of DiaSorin in the United States. In addition, this deal will render access to Luminex's services throughout the Life Science industry, and will also provide access to academic and scientific research.

In September 2021, Roche declared the commercialization of three molecular PCR diagnostic tests which can detect and differentiate common respiratory pathogens simultaneously, of which one test is the detection and identification of influenza A, influenza B, and respiratory syncytial virus (RSV). All three tests can be performed together or individually from a single nasopharyngeal swab specimen.

The Report Will Contains A Crucial Chapter
• Patent Analysis
• Regulatory Framework
• Technology Roadmap
• BCG Matrix
• Heat Map Analysis
• Price Trend Analysis
• Investment Analysis
• Company Profiling and Competitive Positioning
• Industry Value Chain Analysis
• Market Dynamics and Factors
• Porter's Five Forces Analysis
• Pestle Analysis
• SWOT Analysis

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@
https://introspectivemarketresearch.com/checkout/?user=1&_sid=15919

𝐁𝐫𝐨𝐰𝐬𝐞 𝐦𝐨𝐫𝐞 𝐫𝐞𝐩𝐨𝐫𝐭𝐬:
https://introspectivemarketresearch.com/reports/internet-of-things-iot-in-construction-market/

https://introspectivemarketresearch.com/reports/us-kids-food-and-beverage-market/

https://introspectivemarketresearch.com/reports/wealth-management-market/

https://introspectivemarketresearch.com/reports/millimeter-wave-technology-market/

https://introspectivemarketresearch.com/reports/outsourced-semiconductor-assembly-and-test-services-market/

https://introspectivemarketresearch.com/reports/christmas-tree-market/

Contact Us:
Mike Cooper
Business Development Manager
3001 S King Drive, Chicago, Illinois,
U.S. A 60616
Contact No: USA: +1 (773)-382-1049 / IND: +91-81-8009-6367
Email: sales@introspectivemarketresearch.com

About Us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.